EOFlow is sharing full English version of our recent analyst report from Shinhan Investment Corp. published on March 9th.
It was written by two pharmaceutical/bio analysts DongGun Lee and JaeHee Won.
Please refer to the attached file for the report and the article from Business Korea posted on March 10th.
-EOPatch’s debut in Korean market on March 29
-EOPatch will be sold through the domestic partner Huons in online channel
-EOFlow plans to ramp up sales to a European partner Menarini after obtaining the CE marking in May
-with the schedule for EOPatch taking shape, related earnings momentum should pick up
-Plans to expand into markets for wearable artificial pancreas/kidney and non-insulin drug delivery solutions
Thank you for your interest and support, and we will always keep you posted!
If you have further questions, please send an email to firstname.lastname@example.org.